Wednesday, October 20, 2021

chronic bronchitis

Cipla gets USFDA nod for inhalation product

The company has received final approval for its abbreviated new drug application (ANDA) for Arformoterol Tartrate Inhalation Solution 15 mcg/2 mL from the United States Food and Drug Administration (US FDA), Cipla said

Latest News

- Advertisement -